Obermatt
See Similar Stocks →

Eupraxia Pharmaceuticals

TOR:EPRX · CA29842P1053
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings57
Price/Book25
Dividend Yield—
Revenue Growth—
Profit Growth89
Capital Growth36
TSR 52w50
Leverage75
Liquidity25
Refinancing55
Combined—
Analyst Opinions100
Pro Holdings27
Opinion Changes88
Market Pulse43

Profile

CountryCanada
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeTSX
Founded2011
Websiteeupraxiapharma.com/home/default.aspx
ISINCA29842P1053
Last UpdateApr 2, 2026
Index & Theme
GastroenterologyPain ManagementOrthopaedicsInflammationImmunologyBiotechnologyMedicalPharmaceutical

Description

Eupraxia Pharmaceuticals Inc. (Eupraxia) is a clinical-stage biotechnology company. The company is seeking to leverage its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet medical needs. Each of th…

Similar Stocks

The companies this stock is ranked against.

Compare Eupraxia Pharmaceuticals with its peers
Apogee Therapeutics
NMQ:APGE
58
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Sellas Life Sciences
NAQ:SLS
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Tharimmune
NAQ:THAR
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Acumen Pharmaceuticals
NSQ:ABOS
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Tectonic Therapeutic
NMQ:TECX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Oruka Therapeutics
NMQ:ORKA
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →